EE244 Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO
Abstract
Authors
Francisco Prota Ricardo Bueno Nanci Utida